Corteva CTVA Balance Sheet Statement
| TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | TTM Q3 '24 | ||
|---|---|---|---|---|---|---|
| $2.51B+3.6% | $2.07B+12.3% | $2.01B+33.4% | $3.11B+17.5% | $2.42B+7.4% | ||
| $7.78B+17.0% | $8.67B+13.9% | $8.29B+4.9% | $5.68B+3.4% | $6.65B+1.1% | ||
| $5.31B-6.4% | $4.32B-11.8% | $5.13B-17.0% | $5.43B-21.3% | $5.67B-10.2% | ||
| $16.44B+5.0% | $16B+4.2% | $16.59B-3.4% | $15.1B-7.2% | $15.65B-4.2% | ||
| $4.2B-0.2% | $4.15B0.0% | $4.11B-2.4% | $4.1B-4.4% | $4.21B-2.5% | ||
| $5.43B+8.1% | $5.3B+7.5% | $5.14B+6.9% | $4.98B+6.6% | $5.03B+9.9% | ||
| $10.51B-1.1% | $10.52B+0.3% | $10.33B-2.1% | $10.41B-1.9% | $10.63B+1.8% | ||
| $42.2B+0.7% | $41.76B+0.7% | $42.12B-3.4% | $40.83B-5.0% | $41.91B-2.8% | ||
| $4.34B+15.6% | $3.83B+16.0% | $3.91B+8.3% | $4.04B-5.6% | $3.75B+2.0% | ||
| $483M+12.6% | $358M-13.3% | $2.63B-2.3% | $3.29B-3.5% | $429M-22.3% | ||
| $788M+57.6% | $1.28B— | $673M— | $500M— | $500M— | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $1M0.0% | ||
| $10.42B0.0% | $9.52B+6.3% | $11.48B+1.3% | $10.39B-0.2% | $10.42B+0.7% | ||
| $0— | $0— | $0-100% | $0-100% | $0-100% | ||
| $2.04B+30.7% | $1.92B+22.9% | $1.72B+8.1% | $1.71B+3.4% | $1.56B-8.6% | ||
| $6.32B-2.9% | $6.09B-14.1% | $6.12B-16.1% | $6.41B-12.3% | $6.51B-10.8% | ||
| $27.04B-1.7% | $27.01B-1.8% | $26.96B-1.8% | $27.2B-2.0% | $27.52B-1.4% | ||
| $834M+751% | $1.53B+54.4% | $587M+94.4% | $55M+234% | $98M-69.8% | ||
| -$2.66B+7.8% | -$2.64B+20.5% | -$3.27B-8.7% | -$3.47B-29.6% | -$2.89B+3.8% | ||
| $25.22B+1.9% | $25.91B+2.9% | $24.29B-1.9% | $23.79B-5.0% | $24.74B-1.9% | ||
| $42.2B+0.7% | $41.76B+0.7% | $42.12B-3.4% | $40.83B-5.0% | $41.91B-2.8% | ||
| $758M-8.8% | $873M-2.1% | $1.15B-18.6% | $820M-27.5% | $831M-22.3% | ||
| $2.04B+24.3% | $1.92B+22.1% | $1.83B+15.7% | $1.81B+19.2% | $1.64B+5.3% | ||
| $434M-23.0% | $449M-16.5% | $413M-25.0% | $401M-31.3% | $564M+1.8% | ||
| $8.43B-7.2% | $8.58B-7.1% | $8.72B-7.7% | $8.88B-7.8% | $9.08B-7.3% | ||
| $2.04B+24.3% | $1.92B+22.1% | $1.83B+15.7% | $1.81B+19.2% | $1.64B+5.3% | ||
| $9.63B+4.3% | $9.46B+4.0% | $9.24B+2.6% | $9.07B+1.3% | $9.24B+3.9% | ||
| $77M+6.9% | $76M-36.7% | $1M-99.3% | $63M-35.7% | $72M-33.3% | ||
| $2.04B+24.3% | $1.92B+22.1% | $1.83B+15.7% | $1.81B+19.2% | $1.64B+5.3% | ||
| $2.66B+21.6% | $2.9B+16.2% | $2.33B-9.4% | $2.1B-10.5% | $2.19B-3.7% | ||
| $254M-18.8% | $485M-0.6% | $322M+3.5% | $207M+19.0% | $313M+32.6% | ||
| $2.66B+21.6% | $2.9B+16.2% | $2.33B-9.4% | $2.1B-10.5% | $2.19B-3.7% | ||
| $2.22B-10.4% | $2.23B-9.1% | $2.24B-8.7% | $2.27B-7.9% | $2.47B+11.0% | ||
| $1.69B-14.5% | $1.69B-31.7% | $1.79B-28.1% | $1.95B-14.8% | $1.98B-13.8% | ||
| $2.22B-10.4% | $2.23B-9.1% | $2.24B-8.7% | $2.27B-7.9% | $2.47B+11.0% | ||
| $7M0.0% | $7M0.0% | $7M0.0% | $7M0.0% | $7M0.0% | ||
| $9.63B+4.3% | $9.46B+4.0% | $9.24B+2.6% | $9.07B+1.3% | $9.24B+3.9% | ||
| $2.69B-28.2% | $1.94B-13.8% | $2.29B+6.7% | $750M+279% | $3.74B+3.7% | ||
| $373M-24.8% | $258M-57.5% | $369M-51.0% | $478M-46.8% | $496M-53.6% | ||
| $141M+10.2% | $134M+18.6% | $136M+10.6% | $134M+16.5% | $128M+20.8% | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $1M0.0% | ||
| $1.69B-14.5% | $1.69B-31.7% | $1.79B-28.1% | $1.95B-14.8% | $1.98B-13.8% | ||
| $242M0.0% | $242M0.0% | $242M+0.4% | $241M-0.4% | $242M+0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corteva's total assets?
- Corteva (CTVA) holds $42.2B in total assets, up 0.7% year over year.
- How much debt does Corteva have?
- Corteva carries $788.0M in total debt against $25.2B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Corteva have?
- Corteva holds $2.5B in cash and equivalents.
- Can Corteva cover its short-term obligations?
- Its current ratio is 1.58 — current assets exceed current liabilities.
- Where does Corteva's balance sheet data come from?
- Every line is extracted from Corteva's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
